News | Cardiovascular Business | October 20, 2022

Atlas Healthcare Partners and MedAxiom Unveil Cardiovascular ASC Solution, MedAtlas CV

MedAtlas CV will transform cardiovascular care delivery and expand patient access

MedAtlas CV will transform cardiovascular care delivery and expand patient access

October 20, 2022 — Atlas Healthcare Partners – which specializes in developing and managing ambulatory surgery centers (ASCs) – and MedAxiom – which is dedicated to cardiovascular organizational performance improvement –announced the unveiling of its new joint venture, MedAtlas CV. In June, Atlas and MedAxiom partnered to form a cardiovascular-focused ASC company that will transform cardiovascular care by expanding access to high-quality, patient-centered heart care in ASCs. The launch of MedAtlas CV represents a crucial shift in access to and delivery of expert cardiovascular care. 

"We are thrilled with the launch of MedAtlas CV as it showcases how the new company will transform cardiovascular care delivery and expand patient access by providing the best patient and provider experience, driving efficient ASC performance, and delivering high-quality cardiovascular care in ASCs," said Marc Toth, Atlas market president for cardiovascular. 

"MedAtlas CV will provide a better experience for physicians and patients through strategic alignments, including bridging the gap between health systems and physicians," said Jerry Blackwell, MD, MBA, FACC, MedAxiom president and CEO. "The combination of Atlas' expertise in ASC development and management, and MedAxiom's deep insights into cardiovascular care delivery, ensures high-quality clinical and patient outcomes." 

For more information: medatlascv.com 


Related Content

News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
News | Cardiovascular Business

June 28, 2024 — After a year of dedicated service and outstanding leadership, Jodie L. Hurwitz, MD, FHRS, has now ended ...

Home June 28, 2024
Home
Subscribe Now